Dr. Paul M. Yonover, MD

  • Chicago, IL
  • Urologist
NPI1558356253PAC ID1951293943
Medicare services, 2024
4,093
Medicare patients, 2024
452
Part D claims, 2024
1,722
Publications
9
Clinical trials
2
Practice address
1011 W Wellington Ave, Chicago, IL 60657
Practice phone
Call (224) 260-3100
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Uropartners

Chicago, Illinois

See all 7 affiliations

Find Dr. Yonover's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Paul M. Yonover is a urologist in Chicago, Illinois

Dr. Yonover practices at Uropartners in Chicago, Illinois.

Dr. Yonover's NPI, 1558356253, was assigned on September 19, 2005. Dr. Yonover graduated from Icahn School of Medicine at Mount Sinai in 1997. Dr. Yonover holds Illinois license 036101015.

NPI and contact details
Medicare PAC ID
1951293943
NPI enumeration date
September 19, 2005
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(224) 260-3100
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
55
Medical school graduation
1997

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Paul M. Yonover practices at Uropartners in Chicago, Illinois

Dr. Yonover's primary practice is Uropartners, at 1011 W Wellington Ave, Chicago, IL 60657 in Cook County. The practice phone is (224) 260-3100.

  • Uropartners
    1011 W Wellington Ave, Chicago, IL 60657 · Cook CountyPhone(224) 260-3100

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Paul M. Yonover is affiliated with 6 sites of care and 1 medical group

Dr. Yonover's primary practice is Uropartners in Chicago, Illinois. Dr. Yonover is also affiliated with Northwestern Memorial Hospital. The medical group on file is UroPartners. Dmand AI also links Dr. Yonover to 3 more hospitals and 1 group practice or clinic, each named with a free account.

See all 7 affiliations for Dr. Yonover

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Paul M. Yonover's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yonover practices, 5 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UropartnersAvailable with a free account
+5 more affiliated sitesAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Yonover practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Paul M. Yonover is one of 513 urologists in Illinois

Urology is Dr. Yonover's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Yonover is licensed in Illinois.

Specialties and state licenses

  • Urology, IllinoisPrimaryLicense 036101015 · taxonomy 208800000X

Urologists near Dr. Yonover

Counts of urologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Paul M. Yonover billed Medicare for 4,093 services in 2024

CMS data shows 4,093 Medicare services from Dr. Yonover across 26 procedure codes in 2024, for 452 Medicare patients. Medicare paid $203,558 for them.

Medicare services, 20244,093
Medicare patients452
Paid by Medicare$203,558
Procedure codes26

Dr. Yonover's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,1822024: 1,30010%
Surgery
2023: 6992024: 1,06653%
Drugs given in the office
2023: 9242024: 8825%
Other services
2023: 02024: 559
Lab and pathology
2023: 2742024: 19330%
Imaging
2023: 172024: 57235%
Tests and treatments
2023: 282024: 3629%

Where Dr. Yonover's Medicare services took place, 2024

  • In an office4,04199%
  • In a facility521%

Dr. Yonover compared with the Illinois median for urologists, 2024

  • Dr. Yonover
  • Illinois median
Medicare services
4,093vs 1,3233.1 times
Medicare patients
452vs 4908% below
Part D claims
1,616vs 3584.5 times

Medians across 498 urologists in Illinois with Dmand AI profiles that report each measure.

Dr. Yonover's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Yonover

Need commercial claims for Dr. Yonover?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Yonover and other urologists in Illinois.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Paul M. Yonover treated 452 Medicare patients in 2024, average age 75

CMS counts 452 Medicare patients who saw Dr. Yonover in 2024. The largest group is 65 to 74, with 223 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.21, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Yonover's median patient age at 67, with 9% women.

Medicare patients, 2024452
Average age75
Average risk score1.21
Also on Medicaid8%

Dr. Yonover's Medicare patients by age, 2024

Dr. Yonover's Medicare patients by sex, 2024

  • Women378%
  • Men41592%

Chronic conditions among Dr. Yonover's Medicare patients, 2024

  1. High cholesterol75%
  2. High blood pressure72%
  3. Arthritis41%
  4. Cancer38%
  5. Ischemic heart disease33%
  6. Diabetes30%
  7. Chronic kidney disease25%
  8. Mood disorders19%

Share of Medicare patients with each condition. A patient can have several.

Dr. Yonover's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 67

Patient panel by sex, all payers

  • Women9%
  • Men90%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Paul M. Yonover wrote 1,722 Medicare Part D claims in 2024

In 2024, Dr. Yonover wrote 1,722 Medicare Part D claims for 331 patients. 89% of them were for generic drugs. CMS names the drug for 1,616 of them, across 20 drugs with 11 or more claims each, at $381,196 in total drug cost. In 2023, CMS named 1,403 claims across 16 drugs.

Part D claims, 20241,722
Drugs named by CMS20
Total drug cost$381,196
Part D patients331

Dr. Yonover's Part D claims by kind of drug, 2024

  • Generic1,539 claims89%
  • Brand-name183 claims11%

Dr. Yonover's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Yonover's Part D claims, 2024

  • Antibiotics5%86 of 1,722 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1,4032024: 1,61615%

Drugs named by CMS: 20 in 2024, 16 in 2023.

See all prescribing by Dr. Yonover

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Paul M. Yonover scored 75 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Yonover for performance year 2024, reported as part of a group. Dr. Yonover accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes
MIPS final score, 2024
75 of 100

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find urologists like Dr. Yonover by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Paul M. Yonover has 9 publications on record

Dmand AI links 9 papers to Dr. Yonover, published from 2016 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms, Biomarkers, Tumor and Prostate-Specific Antigen. Dr. Yonover's most frequent co-authors are Alexander Chow, MD, Todd Douglas Cohen, MD and Scott Egon Eggener.

Papers9
Years published2016 to 2025

Dr. Yonover's papers by year, 2016 to 2025

Topics Dr. Yonover writes about most

  • Prostatic Neoplasms
  • Biomarkers, Tumor
  • Prostate-Specific Antigen
  • Biopsy
  • Carboxylic Acids
  • Cyclobutanes
  • Neoplasm Grading
  • Positron Emission Tomography Computed Tomography

Dr. Yonover's most frequent co-authors

Recent publications by Dr. Yonover

See all 9 publications and co-authors

See who Dr. Yonover researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Yonover works with, so you can find a warm path to the right urologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Paul M. Yonover has worked on 2 clinical trials

Dmand AI links Dr. Yonover to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Myriad Genetic Laboratories, Inc. sponsors the most, 2.

Conditions in Dr. Yonover's trials

  • Prostatic Neoplasms
  • Prostatic Diseases

Investigators on the most trials with Dr. Yonover

Recent clinical trials with Dr. Yonover

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Paul M. Yonover received $225,413 in industry payments from 2016 to 2025

CMS Open Payments shows 720 general payments to Dr. Yonover from 69 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 54% of the total. Telix Pharmaceuticals paid the most, $96,123.

General payments to Dr. Yonover by program year, 2016 to 2025

General payments to Dr. Yonover by kind, 2016 to 2025

$225.4Kin total
  • Consulting fees$122,38354%
  • Speaker and faculty fees$46,45521%
  • Travel and lodging$29,54713%
  • Food and beverage$19,1548%
  • Other$7,8743%

Companies that paid Dr. Yonover the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Yonover

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Paul M. Yonover graduated from Icahn School of Medicine at Mount Sinai

Dr. Yonover graduated from Icahn School of Medicine at Mount Sinai in 1997.

  1. Medical schoolIcahn School of Medicine at Mount Sinai

Source: Dmand AI Professional Profile Data

Sources for Dr. Paul M. Yonover's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Paul M. Yonover

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Paul M. Yonover's NPI number?

Dr. Paul M. Yonover's NPI number is 1558356253. It was assigned on September 19, 2005, and it is active in the NPI Registry.

What kind of doctor is Dr. Paul M. Yonover?

Dr. Paul M. Yonover is a urologist in Chicago, Illinois. The primary specialty in the NPI Registry is Urology Physician (taxonomy code 208800000X).

Where does Dr. Paul M. Yonover practice?

Dr. Yonover practices at 1011 W Wellington Ave, Chicago, IL 60657. Dr. Yonover's primary practice is Uropartners in Chicago, Illinois. Dmand AI also links Dr. Yonover to 3 hospitals and 1 group practice or clinic.

What is Dr. Paul M. Yonover's office phone number?

The practice phone on file for Dr. Yonover is (224) 260-3100.

What is Dr. Paul M. Yonover's medical license number?

Dr. Yonover holds Illinois license 036101015.

Which hospitals is Dr. Paul M. Yonover affiliated with?

Dr. Yonover is affiliated with Northwestern Memorial Hospital. Dmand AI links Dr. Yonover to 3 more hospitals.

What medical group is Dr. Paul M. Yonover part of?

Dr. Yonover is linked to UroPartners.

Does Dr. Paul M. Yonover accept Medicare?

Yes. CMS data shows Dr. Yonover billed Medicare for 4,093 services in 2024, and Dr. Yonover accepts Medicare assignment.

What is Dr. Paul M. Yonover's MIPS score?

Dr. Yonover's MIPS final score for performance year 2024 is 75 out of 100, reported as part of a group.

How many Medicare patients does Dr. Paul M. Yonover see?

CMS counts 452 Medicare patients who saw Dr. Yonover in 2024, with an average age of 75.

Show 7 more questionsShow fewer questions

What services does Dr. Paul M. Yonover bill to Medicare?

In 2024, Dr. Yonover's most billed Medicare services were injected or infused drug (J1952), medicare service (G2211) and office visit, established patient (99214).

Where did Dr. Paul M. Yonover go to medical school?

Dr. Yonover graduated from Icahn School of Medicine at Mount Sinai in 1997.

What drugs does Dr. Paul M. Yonover prescribe most?

In 2024 Medicare Part D data, Dr. Yonover's most prescribed drugs by claims were Tamsulosin HCl, Finasteride and Myrbetriq.

Has Dr. Paul M. Yonover received payments from drug or device companies?

CMS Open Payments shows $225,413 in general payments to Dr. Yonover from 69 companies from 2016 to 2025. The largest total came from Telix Pharmaceuticals.

How long has Dr. Paul M. Yonover been practicing?

Dr. Yonover graduated from medical school in 1997, 29 years ago.

Does Dr. Paul M. Yonover do research?

Dmand AI links 9 publications to Dr. Yonover, published from 2016 to 2025. Dr. Yonover has worked on 2 clinical trials.

Who does Dr. Paul M. Yonover publish with?

Dr. Yonover's most frequent co-authors are Alexander Chow, MD (2 shared papers), Todd Douglas Cohen, MD (2 shared papers) and Scott Egon Eggener (2 shared papers).

Selling to urology practices?

See urologists in Illinois by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)